Matthew G Jenks

This inventor holds 4 USPTO granted patents and 2 published patent applications and 3 EPO patents. Top assignees: Merck Patent Gmbh, Merck Sharp + Dohme Corp., Msd K.k.. Active years: 2008-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Matthew G Jenks. Retrieved from https://idiyas.com/inventor/matthew-g-jenks

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 (Patent Applications = 2)

% Patents Active = 50.0

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 6.6

ph-index = 2

Forward Citations = 9(Granted Patents)

Company Filing History:

Merck Sharp + Dohme Corp.

where one patent can have more than one assignee

Years Active: 2008-2019

Loading Chart...

4 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10183935 - Benzamide derivatives as modulators of the follicle stimulating hormone (2019-01-22),

2. 9409897 - Benzamide derivatives as modulators of the follicle stimulating hormone (2016-08-09),

3. 8614221 - Inhibitors of Akt activity (2013-12-24),

4. 7371852 - Alkyl-linked nucleotide compositions (2008-05-13),

Title: The Innovative Contributions of Matthew G. Jenks

Introduction

Matthew G. Jenks is a notable inventor based in Durham, NC, who has made significant contributions to the field of pharmaceuticals. With a total of four patents to his name, he has focused on developing novel compounds that can aid in the treatment of fertility disorders.

Latest Patents

Among his latest patents are benzamide derivatives that serve as positive allosteric modulators of the follicle-stimulating hormone (FSH) receptor. These novel benzamide derivatives, characterized by specific chemical formulas, have the potential to be employed in treating various fertility disorders. The innovative nature of these compounds highlights Jenks' commitment to advancing medical science.

Career Highlights

Throughout his career, Matthew G. Jenks has worked with prominent companies such as Merck Patent GmbH and Serenex, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Jenks has collaborated with esteemed colleagues, including Henry Yu and Thomas E. Richardson. These partnerships have fostered an environment of innovation and creativity, further enhancing the impact of his work.

Conclusion

Matthew G. Jenks exemplifies the spirit of innovation in the pharmaceutical field. His contributions, particularly in the development of benzamide derivatives, showcase his dedication to improving fertility treatments. His work continues to inspire future advancements in medical research.

Profile summary based on public USPTO records.